Rickets and a medium chain triglyceride diet

1973 ◽  
Vol 8 (3) ◽  
pp. 439-440 ◽  
Author(s):  
James P. Keating ◽  
Donald B. Strominger ◽  
John Poulos
Keyword(s):  
Medium Chain Triglyceride ◽  
Medium Chain ◽  
Medium Chain Triglyceride Diet

scholarly journals The medium chain triglyceride diet and intractable epilepsy.

1986 ◽  
Vol 61 (12) ◽  
pp. 1168-1172 ◽  
Author(s):  
M A Sills ◽  
W I Forsythe ◽  
D Haidukewych ◽  
A MacDonald ◽  
M Robinson
Keyword(s):  
Intractable Epilepsy ◽  
Medium Chain Triglyceride ◽  
Medium Chain ◽  
Medium Chain Triglyceride Diet

Protective effects of medium chain triglyceride diet in a mouse model of Dravet syndrome

Epilepsia ◽  
2021 ◽  
Author(s):  
Nikola Jancovski ◽  
Tomas Baldwin ◽  
Michael Orford ◽  
Melody Li ◽  
Gabriel Davis Jones ◽  
...  
Keyword(s):  
Mouse Model ◽  
Medium Chain Triglyceride ◽  
Dravet Syndrome ◽  
Protective Effects ◽  
Medium Chain ◽  
Medium Chain Triglyceride Diet

Refractory primary intestinal lymphangiectasia effectively managed with subcutaneous octreotide

2021 ◽  
Vol 14 (4) ◽  
pp. e238457
Author(s):  
Amir Halim ◽  
Philippa Youd ◽  
Jill Thorpe ◽  
Irfan Halim
Keyword(s):  
Case Report ◽  
Gastrointestinal Symptoms ◽  
Medium Chain Triglyceride ◽  
Well Being ◽  
Intestinal Lymphangiectasia ◽  
Curative Therapy ◽  
Medium Chain ◽  
History Of ◽  
Medium Chain Triglyceride Diet ◽  
Conventional Medium

This case report describes a young man with a history of lymphoedema and long-standing gastrointestinal symptoms since childhood. After undergoing extensive investigations, he was diagnosed with primary intestinal lymphangiectasia (IL). The patient’s condition was refractory to conventional medium-chain triglyceride diet but responded well to treatment with subcutaneous octreotide. We have shown octreotide to be effective in improving the pathological effects of primary IL, associated with improved clinical well-being and serology, but it is not a curative therapy.

Sign in / Sign up

Export Citation Format

Share Document